Episode 27: Management of Patients with APOL1 Kidney Disease

https://is1-ssl.mzstatic.com/image/thumb/Podcasts125/v4/31/f7/3d/31f73de3-e13a-79d8-1556-ce5e9782f2db/mza_1882848660028699420.jpg/600x600bb.jpg

KDIGO Conversations in Nephrology

KDIGO Communications

28 episodes

2 days ago

KDIGO Conversations in Nephrology features global experts covering a wide range of topics for clinicians treating patients with kidney disease.

Medicine

Health & Fitness

RSS

All content for KDIGO Conversations in Nephrology is the property of KDIGO Communications and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

KDIGO Conversations in Nephrology features global experts covering a wide range of topics for clinicians treating patients with kidney disease.

Medicine

Health & Fitness

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/17207138/17207138-1761657344876-8af4d3490c87.jpg

Episode 27: Management of Patients with APOL1 Kidney Disease

KDIGO Conversations in Nephrology

19 minutes 15 seconds

1 week ago

Episode 27: Management of Patients with APOL1 Kidney Disease

In this second installment of KDIGO’s three-part podcast series on APOL1 kidney disease, host Kirk Campbell, MD (University of Pennsylvania, United States), welcomes Barry Freedman, MD (Wake Forest University School of Medicine, United States) for a practical discussion on patient management.

They examine how APOL1 risk variants influence progression, review current therapeutic approaches, and explore emerging targeted treatments designed to improve care and outcomes for affected individuals.

Learn more and access resources from the KDIGO Controversies Conference on APOL1 Kidney Disease: https://kdigo.org/conferences/apol1-kidney-disease/

This podcast was supported by Vertex Pharmaceuticals.